Biomarkers as predicting factors for relapse in polymyalgia rheumatica: the importance of alkaline phosphatase

Rheumatology (Oxford). 2023 Oct 3;62(10):e288-e290. doi: 10.1093/rheumatology/kead137.

Authors

Kenji Ishiguro¹, Hiroyuki Yamashita¹, Yosuke Shimizu², Hiroshi Kaneko¹

Affiliations

¹ Division of Rheumatic Diseases, National Center for Global Health and Medicine, Tokyo, Japan.
² Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.

PMID: 37014366
DOI: 10.1093/rheumatology/kead137

No abstract available

Publication types

Letter

MeSH terms

Alkaline Phosphatase
Biomarkers
Chronic Disease
Giant Cell Arteritis*
Humans
Polymyalgia Rheumatica* / diagnosis
Polymyalgia Rheumatica* / drug therapy
Recurrence

Substances

Alkaline Phosphatase
Biomarkers